# The Prophet Trial -Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Patients With Pulmonary Hypertension

> **NCT03022851** · NA · COMPLETED · sponsor: **Occlutech International AB** · enrollment: 32 (actual)

## Conditions studied

- Pulmonary Hypertension

## Interventions

- **DEVICE:** Occlutech AFR Device

## Key facts

- **NCT ID:** NCT03022851
- **Lead sponsor:** Occlutech International AB
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-19
- **Primary completion:** 2024-01-08
- **Final completion:** 2024-01-08
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2025-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03022851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03022851, "The Prophet Trial -Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Patients With Pulmonary Hypertension". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03022851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*